Wu Licia N Y, Sauer Glenn R, Genge Brian R, Valhmu Wilmot B, Wuthier Roy E
Department of Chemistry and Biochemistry, University of South Carolina, 329 Graduate Science Research Center, 631 Sumter, Columbia, SC 29208, USA.
J Inorg Biochem. 2003 Mar 1;94(3):221-35. doi: 10.1016/s0162-0134(03)00003-5.
The mechanism of matrix vesicle (MV) mineralization was studied using MVs isolated from normal growth plate tissue, as well as several putative intermediates in the MV mineralization pathway--amorphous calcium phosphate (ACP), calcium phosphate phosphatidylserine complex (CPLX) and hydroxyapatite (HAP). Radionuclide uptake and increase in turbidity were used to monitor mineral formation during incubation in synthetic cartilage lymph (SCL). Inhibitors of phosphate (Pi) metabolism, as well as replacing Na(+) with various cations, were used to study MV Pi transport, which had been thought to be Na(+)-dependent. MVs induced rapid mineralization approximately 3 h after addition to SCL; CPLX and HAP caused almost immediate induction; ACP required approximately 1 h. Phosphonoformate (PFA), a Pi analog, potently delayed the onset and reduced the rate of mineral formation of MV and the intermediates with IC(50)'s of 3-6 microM and approximately 10 microM, respectively. PFA:Pi molar ratios required to reduce the rate of rapid mineralization by 50% were approximately 1:30 for ACP, approximately 1:20 for HAP, approximately 1:3.3 for CPLX, and approximately 1:2.0 for MVs. MV mineralization was not found to be strictly Na(+)-dependent: substitution of Li(+) or K(+) for Na(+) had minimal effect; while N-methyl D-glucamine (NMG(+)) was totally inhibitory, choline(+) was clearly stimulatory. Na(+) substitutions had minimal effect on HAP- and CPLX-seeded mineral formation. However with ACP, NMG(+) totally blocked and choline(+) stimulated, just as they did MV mineralization. Thus, kinetic analyses indicate that ACP is a key intermediate, nevertheless, formation of CPLX appears to be the rate-limiting factor in MV mineralization.
利用从正常生长板组织中分离出的基质小泡(MV)以及MV矿化途径中的几种假定中间体——无定形磷酸钙(ACP)、磷酸钙磷脂丝氨酸复合物(CPLX)和羟基磷灰石(HAP),对MV矿化机制进行了研究。在合成软骨淋巴液(SCL)中孵育期间,利用放射性核素摄取和浊度增加来监测矿物质形成。使用磷酸盐(Pi)代谢抑制剂以及用各种阳离子替代Na(+),来研究曾被认为依赖于Na(+)的MV Pi转运。MV添加到SCL中约3小时后诱导快速矿化;CPLX和HAP几乎立即诱导矿化;ACP需要约1小时。膦甲酸(PFA)是一种Pi类似物,有力地延迟了MV和中间体矿化的起始并降低了其速率,其半数抑制浓度(IC(50))分别为3 - 6 microM和约10 microM。将快速矿化速率降低50%所需的PFA:Pi摩尔比,对于ACP约为1:30,对于HAP约为1:20,对于CPLX约为1:3.3,对于MV约为1:2.0。未发现MV矿化严格依赖于Na(+):用Li(+)或K(+)替代Na(+)影响极小;而N - 甲基 - D - 葡糖胺(NMG(+))具有完全抑制作用,胆碱(+)则明显具有刺激作用。Na(+)替代对HAP和CPLX引发的矿化形成影响极小。然而对于ACP,NMG(+)完全阻断而胆碱(+)刺激矿化,就如同它们对MV矿化的作用一样。因此,动力学分析表明ACP是关键中间体,尽管如此,CPLX的形成似乎是MV矿化中的限速因素。